Roche Diagnostics Corporation Confirm Cd8 (Sp57) Rabbitmono

Roche Diagnostics Corporation confirm cd8 (sp57) rabbitmono; ventana medical systems, inc. (ventana) confirm anti-cd8 (sp57) rabbit monoclonal primary antibody (confirm anti-cd8 (sp57)) is intended for the qualitative detection of cd8 in sections of normal and neoplastic human tissues. the cd8 glycoprotein is present on cytotoxic/suppressor t lymphocytes that recognize antigen in the context of mhc class 1 molecules. cd8 positive staining results may aid in identifying t-cell lymphomas and in identifying the t cytotoxic/suppressor cell subset of t lymphocytes in normal tissues. the antibody is intended for qualitative staining in sections of formalin-fixed, paraffin-embedded tissue. this product should be interpreted by a qualified pathologist in conjunction with histological examination, relevant clinical information and proper controls. this antibody is intended for in vitro diagnostic (ivd) use. - ROCHMSD (Additional S&H or Hazmat Fees May Apply)